NMR-Metabolomics in COVID-19 Research

• Published in: Advances in experimental medicine and biology Vol. 1412; p. 197
• Main Authors: de Moraes Pontes, João Guilherme, Dos Santos, Roney Vander, Tasic, Ljubica
• Format: Journal Article
• Language: English
• Published: United States 2023
• Subjects: Antiviral Agents - therapeutic use; COVID-19; Cytokines; Humans; Metabolomics; SARS-CoV-2; COVID-19; Metabolomics; SARS-CoV-2; Biomarkers; NMR spectroscopy; COVIDomics; Thrombosis
• ISSN: 0065-2598
• DOI: 10.1007/978-3-031-28012-2_10

COVID-19 stands for Corona Virus Disease 2019, which starts as a viral infection that provokes illness with different symptoms and severity. The infected individuals can be asymptomatic or present with mild, moderate, severe, and critical illness with acute respiratory distress syndrome (ARDS), acute cardiac injury, and multiorgan failure. When the virus enters the cells, it replicates and provokes responses. Most diseased individuals resolve the problems in a short time but unfortunately, some may die, and almost 3 years after the first reported cases, COVID-19 still kills thousands per day worldwide. One of the problems in not curing the viral infection is that the virus passes by undetected in cells. This can be caused by the lack of pathogen-associated molecular patterns (PAMPs) that start an orchestrated immune response, such as activation of type 1 interferons (IFNs), inflammatory cytokines, chemokines, and antiviral defenses. Before all of these events can happen, the virus uses the infected cells and numerous small molecules as sources of energy and building blocks for newly synthesized viral nanoparticles that travel to and infect other host cells. Therefore, studying the cell metabolome and metabolomic changes in biofluids might give insights into the state of the viral infection, viral loads, and defense response. NMR-metabolomics can help in solving the real-time host interactions by monitoring concentration changes in metabolites. This chapter addresses the state of the art of COVIDomics by NMR analyses and presents exemplified biomolecules identified in different world regions and gravities of illness as potential biomarkers.